Products/Services Used | Details | Operation |
---|---|---|
Catalog Antibody> | The antibodies used in this study were purchased from Santa Cruz Biotechnology (anti- p53, anti-Mdm2, anti-a-tubulin, and anti-PSD-95), Millipore Cor- poration, Bedford, MA, USA (anti-GluA1), Cell Signaling Tech- nology, Beverly, MA, USA (anti-Nedd4-1, anti-Nedd4-2, anti- glutamate receptor subunit 2 (GluA2), anti-phospho-Mdm2, and anti-Ub), Enzo Life Sciences, Farmingdale, NY, USA (anti-Akt), Thermo Scientific, Waltham, Massachusetts, USA (anti-phospho- Akt, anti-Myc, and anti-HA) and Genscript Corporation, Piscataway Township, NJ, USA (anti-Gapdh). | Get A Quote |
Chronic activity perturbation in neurons can trigger homeostatic mechanisms to restore the baseline function. Although the importance and dysregulation of neuronal activity homeostasis has been implicated in neurological disorders such as epilepsy, the complete signaling by which chronic changes in neuronal activity initiate the homeostatic mechanisms is unclear. We report here that the tumor suppressor p53 and its signaling are involved in neuronal activity homeostasis. Upon chronic elevation of neuronal activity in primary cortical neuron cultures, the ubiquitin E3 ligase, murine double minute- 2 (Mdm2), is phosphorylated by the kinase Akt. Phosphorylated Mdm2 triggers the degradation of p53 and subsequent in... More